Quick Answer
Equillium, Inc. reported R&D Expense of $37.04 million for fiscal year 2023.
Equillium, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2023 | $37.04M | -1.4% |
| 2022 | $37.55M | +42.3% |
| 2021 | $26.38M | +36.1% |
| 2020 | $19.38M | +9.9% |
| 2019 | $17.64M | +256.9% |
| 2018 | $4.94M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $6.96M | +65.1% | +16.4% |
| June 30, 2021 | $5.99M | +53.7% | +1.8% |
| March 31, 2021 | $5.88M | +24.9% | +39.4% |
| September 30, 2020 | $4.22M | +0.9% | +8.3% |
| June 30, 2020 | $3.89M | -8.4% | -17.3% |
| March 31, 2020 | $4.71M | +25.2% | +12.5% |
| September 30, 2019 | $4.18M | +242.2% | -1.6% |
| June 30, 2019 | $4.25M | +687.0% | +13.1% |
- Equillium, Inc. showed a decrease of -1.4% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2023 period, Equillium, Inc.’s r&d expense has grown by 649.3% (from $4.94 million to $37.04 million).
- The most recent figure is from Equillium, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 25, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: